Low Efficacy of Antibiotics Against Staphylococcus aureus Airway Colonization in Ventilated Patients
Authors:
- 4 February 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 64 (8) , 1081-1088
Abstract
Airway-colonization by Staphylococcus aureus predisposes to the development of ventilator-associated tracheobronchitis (VAT) and ventilator-associated pneumonia (VAP). Despite extensive antibiotic treatment of intensive care unit patients, limited data are available on the efficacy of antibiotics on bacterial airway colonization and/or prevention of infections. Therefore, microbiologic responses to antibiotic treatment were evaluated in ventilated patients. Results of semiquantitative analyses of S. aureus burden in serial endotracheal-aspirate (ETA) samples and VAT/VAP diagnosis were correlated to antibiotic treatment. Minimum inhibitory concentrations of relevant antibiotics using serially collected isolates were evaluated. Forty-eight mechanically ventilated patients who were S. aureus positive by ETA samples and treated with relevant antibiotics for at least 2 consecutive days were included in the study. Vancomycin failed to reduce methicillin-resistant S. aureus (MRSA) or methicillin-susceptible S. aureus (MSSA) burden in the airways. Oxacillin was ineffective for MSSA colonization in approximately 30% of the patients, and responders were typically coadministered additional antibiotics. Despite antibiotic exposure, 15 of the 39 patients (approximately 38%) colonized only by S. aureus and treated with appropriate antibiotic for at least 2 days still progressed to VAP. Importantly, no change in antibiotic susceptibility of S. aureus isolates was observed during treatment. Staphylococcus aureus colonization levels inversely correlated with the presence of normal respiratory flora. Antibiotic treatment is ineffective in reducing S. aureus colonization in the lower airways and preventing VAT or VAP. Staphylococcus aureus is in competition for colonization with the normal respiratory flora. To improve patient outcomes, alternatives to antibiotics are urgently needed.Keywords
This publication has 36 references indexed in Scilit:
- Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic SocietyClinical Infectious Diseases, 2016
- Antibiotic therapy for ventilator-associated tracheobronchitisCurrent Opinion in Pulmonary Medicine, 2015
- Comparative Effectiveness of Beta-Lactams Versus Vancomycin for Treatment of Methicillin-SusceptibleStaphylococcus aureusBloodstream Infections Among 122 HospitalsClinical Infectious Diseases, 2015
- α-Hemolysin Activity of Methicillin-Susceptible Staphylococcus aureus Predicts Ventilator-associated PneumoniaAmerican Journal of Respiratory and Critical Care Medicine, 2014
- Global Prospective Epidemiologic and Surveillance Study of Ventilator-Associated Pneumonia due to Pseudomonas aeruginosa*Critical Care Medicine, 2014
- Ventilator-Associated PneumoniaSeminars in Respiratory and Critical Care Medicine, 2014
- Incidence and Outcomes of Ventilator-associated Tracheobronchitis and PneumoniaThe American Journal of Medicine, 2013
- Diagnosis of ventilator-associated pneumoniaCurrent Opinion in Infectious Diseases, 2013
- Lack of Bactericidal Antagonism or SynergismIn Vitrobetween Oxacillin and Vancomycin against Methicillin-Susceptible Strains ofStaphylococcus aureusAntimicrobial Agents and Chemotherapy, 2010
- Outcome of Vancomycin Treatment in Patients with Methicillin-SusceptibleStaphylococcus aureusBacteremiaAntimicrobial Agents and Chemotherapy, 2008